Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)

Market Cap	30.34B
Revenue (ttm)	5.57B
Net Income (ttm)	769.03M
Shares Out	354.88M
EPS (ttm)	2.16
PE Ratio	40.69
Forward PE	24.53
Dividend	1.80 (2.05%)
Ex-Dividend Date	Jun 28, 2024

Volume	6,715,753
Average Volume	3,534,299
Open	78.85
Previous Close	85.93
Day's Range	78.85 - 89.44
52-Week Range	59.55 - 110.22
Beta	0.19
RSI	70.99
Earnings Date	Mar 29, 2025

About SHE:002821

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical m...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9,788
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002821

Financial Performance

In 2023, SHE:002821's revenue was 7.83 billion, a decrease of -23.70% compared to the previous year's 10.26 billion. Earnings were 2.27 billion, a decrease of -31.28%.